SEC Form 4 · accession 0000920465-18-000008
LA JOLLA PHARMACEUTICAL CO · LJPC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jennifer Carver
Officer — Chief Operating Officer
Period of report
Feb 23, 2018
Accepted (ET)
Feb 27, 2018 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000920465
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 23, 2018 | P | 1,000 | $32.475 | A | 5,500 | D |
Table II — derivative securities
No Table II lines on this filing.